One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...

Progressing vision to expand the reach of targeted radiopharmaceuticals to large patient populationsAnticipating multiple milestones in the next ...

By David Bautz, PhD NASDAQ: BDRX READ THE FULL BDRX RESEARCH REPORT We are initiating coverage of Biodexa Pharmaceuticals, PLC (NASDAQ: BDRX) with a valuation of $7.00. Biodexa is a clinical-stage GI ...

The Fund outperformed its benchmark in Q4 2025, led by strong selection in semiconductors and hardware. Read the full analysis for more details.

The 1980s were a time of huge economic growth, and many well-known companies that went public on the stock exchange are still ...

Rezpegaldesleukin demonstrates statistically significant improvement in mean percent EASI improvement across both moderate and severe atopic dermatitis patients ...

Announced partnership with Australian CRO to accelerate initiation of CLD-401 clinical trial The Company has received feedback from the FDA through Type D interactions, and the Company believes its ...

Participants with Atopic Dermatitis Receiving ATI-2138 Experienced Improvements in Key Clinical Measures including Disease Severity, Itch, and ...

Lantern Pharma Inc. (NASDAQ: LTRN) and its CNS-oncology focused wholly owned subsidiary Starlight Therapeutics today ...

A Minneapolis woman who confronted federal immigration officers alongside Alex Pretti in January was among a group of ...

(The Hill) – A Costco shopper in Illinois has sued the retail giant in an attempt to secure refunds for U.S. customers after the Supreme Court struck down the bulk of President Donald Trump’s sweeping ...

President Trump revealed Wednesday that he’s been briefed on the possibility Iranian terrorist sleeper cells could be activated to attack Americans. The president indicated he was aware of an alarming ...